1.5735
10-January-25 10:53:44
15 minutes delayed
Stocks
-0.0865
-5.21%
Today's range
1.5600 - 1.6499
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 08:00:00 By Nasdaq GlobeNewswire